Our previous studies showed that IL-33 contributed to the shape of the transcriptome in patients presenting with the clinically isolated syndrome event but prior to diagnosis of clinically definite relapsing remitting MS. This evidence concerns the gene IL33 and relapsing-remitting multiple sclerosis.